Relay Therapeutics RLAY
NASDAQ RLAY
$18.99 +0.50 (+2.70%)
As of: Oct 2, 2026 · 9:34 AM EDT

Relay Therapeutics (RLAY) Accumulated Depreciation (2019 - 2023)

Updated

Relay Therapeutics (RLAY) recorded Accumulated Depreciation of $23.58 million in Q4 2023, up 28.2% from $18.39 million a year earlier.

Analysis

Relay Therapeutics (RLAY) Accumulated Depreciation (2019 - 2023) Analysis & Trends

Starting with Q4 2019, Relay Therapeutics' Accumulated Depreciation history includes 5 quarters.

  • Annual Accumulated Depreciation has increased for four straight years, with a four-year compound annual growth rate of 35.6% (FY2019 to FY2023).
  • Across earlier years, Accumulated Depreciation came in at $18.39 million in FY2022 (+28.0%), $14.37 million in FY2021 (+36.4%), $10.53 million in FY2020 (+50.8%) and $6.98 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Relay Therapeutics 3.94 Bn 3.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 23.58 Mn
Dec 31, 2022 18.39 Mn
Dec 31, 2021 14.37 Mn
Dec 31, 2020 10.53 Mn
Dec 31, 2019 6.98 Mn
API Access

Relay Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=RLAY&period=max&api_key=YOUR_API_KEY